News

Further STEMI progress requires new focus


 

EXPERT OPINION FROM THE ANNUAL CARDIOVASCULAR CONFERENCE AT SNOWMASS

Dr. Gersh reported that he serves as a consultant to Abbott, Boston Scientific, GE Healthcare, and other companies.

b.jancin@elsevier.com

Pages

Recommended Reading

New Strategy Distinguishes Inferior STEMI from Pericarditis
MDedge Cardiology
Survival After In-Hospital Cardiac Arrest Has Improved Substantially
MDedge Cardiology
Pregnancy Loss Boosts Multiple Atherosclerotic Risks
MDedge Cardiology
Guidelines Update Approaches to Stable Ischemic Heart Disease
MDedge Cardiology
Prasugrel's use grows, but often off label
MDedge Cardiology
ED syncope observation protocol safely saves money
MDedge Cardiology
Hospital readmissions under attack
MDedge Cardiology
Stopping aspirin after bleeding ulcer raises CV death rate sixfold
MDedge Cardiology
ED troponin testing called big time saver
MDedge Cardiology
Kawasaki disease: long-term cardiovascular risk quantified
MDedge Cardiology